CAS 1010073-75-2

Formule : C22H22ClN7O2

InChI : InChI=1S/C22H22ClN7O2/c1-32-18-13-15(4-5-17(18)23)28-9-11-29(12-10-28)19(31)14-30-22-16(3-2-6-26-22)20(27-30)21-24-7-8-25-21/h2-8,13H,9-12,14H2,1H3,(H,24,25)

Code InChI : ZIMLRKWQDLVPEK-UHFFFAOYSA-N

SMILES : COC1=C(C=CC(=C1)N2CCN(CC2)C(=O)CN3C4=C(C=CC=N4)C(=N3)C5=NC=CN5)Cl

CCX354

CAS : 1010073-75-2

CCX354

Formule : C₂₂H₂₂ClN₇O₂

Degré de pureté : ≥98%

Masse moléculaire : 451.91

Ref: 54-BUP08693

1-[4-(4-Chloro-3-methoxyphenyl)-1-piperazinyl]-2-[3-(1H-imidazol-2-yl)-1H-pyrazolo[3,4-b]pyridin-1-yl]ethanone

CAS : 1010073-75-2

Formule : C₂₂H₂₂ClN₇O₂

Degré de pureté : 98%

Masse moléculaire : 451.9088

Ref: IN-DA01EOL2

CCX354

CAS : 1010073-75-2

CCX354 (CCR1 antagonist 1) is a potent small molecule CCR1 antagonist with anti-inflammatory activity for the treatment of rheumatoid arthritis.

Formule : C₂₂H₂₂ClN₇O₂

Degré de pureté : 99.43% - 99.44%

Couleur et forme : Solid

Masse moléculaire : 451.909

Ref: TM-T15253

CCX354

Produit contrôlé

CAS : 1010073-75-2

CCX354 is a potent Chinese medicinal compound that acts as a kinase inhibitor. It has been shown to inhibit the cell cycle and induce apoptosis in human leukemia cells, making it a promising candidate for cancer treatment. CCX354 works by blocking the activity of specific proteins involved in tumor growth and survival, leading to decreased proliferation and increased cell death. This compound has also been found to be effective against various cancer cell lines, making it a versatile tool for cancer research. With its potential as a powerful anti-cancer agent, CCX354 represents an exciting new avenue for the development of novel cancer therapies.

Formule : C₂₂H₂₂ClN₇O₂

Degré de pureté : Min. 95%

Masse moléculaire : 451.9 g/mol

Ref: 3D-KQB07375